The seeds were sown in study hall. They sprouted at St. Jude Children’s Research Hospital.
It sounds more like a parable than a game plan for a football team to win a national championship. But it’s just how Lausanne Collegiate School teammates Isaac Weiss and Eric Gray drew it up.
Lausanne, a Memphis private school with a tradition of football dominance, raised more than $19,000 for St. Jude to win the 2018 Touchdowns Against Cancer national championship. The Lynx were led by seniors Weiss, the kicker with an eye toward the Ivy League, and Gray, one of the nation’s top-rated all-purpose backs.
“Being a good football player is half of you,” says Gray, who decided to dedicate his season to St. Jude after a study-hall conversation with Weiss. “You’ve also got to be a good person.”
Gray’s touchdowns raised more than $3,000 for the kids of St. Jude; Weiss’ kicks accounted for more than $11,000.
Touchdowns Against Cancer is a national fundraising program in which St. Jude partners with MaxPreps, a website covering high school sports, and Pledge It, a sports fundraising site. Donors pledge a specific amount per touchdown — or field goal and extra point, in Weiss’s case — or make a one-time donation.
“Basically, my thought process is, this could be my last year playing football,” Weiss says. “No one’s going to remember a high school career playing football, but doing something like Touchdowns Against Cancer and Pledge It really lets me leave something after I’m done.”
As they hoisted the Touchdowns Against Cancer trophy during a visit to the St. Jude campus, the Lynx had an 8-0 record and a No. 1 state ranking. They’d won 35 straight games overall — a streak that began with Weiss’ debut as the team’s kicker.
“They’re leaders, obviously, within our football program. But they’re leaders within our school community,” says Lausanne coach and athletic director Kevin Locastro. “They’re kids who have really good heads on their shoulders. They come up with good ideas and good concepts, and they’re not scared to execute them.”
More articles from this issue
-
A Cancer Chameleon: Mixed-phenotype Acute Leukemia
Features of mixed-phenotype acute leukemia can change, enough to switch the diagnosis from one acute leukemia to the other.
-
Sharing Smiles
Delta Dental and the Smile180 Foundation have donated $2 million to support St. Jude treatment, research and awareness.
-
Science Alliance: Fighting PKAN Together
Married St. Jude researchers broaden their collaboration to develop a novel medication for pantothenate kinase-associated neurodegeneration (PKAN), a life-threatening neurological disorder.
-
St. Jude and WHO Unite to Save Lives
The greatest predictor of survival for a child with cancer is where that child happens to live. St. Jude and World Health Organization join forces to change that sobering fact.
-
Flu Fighters: How the Immune System Protects Infants from Influenza
St. Jude investigators discover how guardian T cells help combat influenza in infants and young children.
-
Dance of the T Cells
A new therapy at St. Jude called CAR T-cell therapy holds hope for many children who have cancer that returns or is hard to treat.
-
Dawn of a New Era for Aggressive Brain Tumors
Relapsed brain tumors have been difficult to treat, but a new approach at St. Jude offers a ray of hope.
-
Cryo-EM: It’s a Small, Small World
Scientists in the new St. Jude Cryo-EM and Tomography Center zoom in on staggeringly small structures to better understand biological systems.
-
Run for a Reason
More than 26,000 runners and walkers recently laced up their shoes for the 2018 St. Jude Memphis Marathon Weekend, the largest single-day fundraising event for St. Jude.
-
Research Highlights - Winter 2019
Learn about whole genome sequencing; the Hippo pathway; scavenger immune cells; tumor suppressor gene SPOP; free acute leukemia models; and more.